We are live on
!
Find out more
E
Ergoteles Portfolio holdings
AUM
$68.2M
1-Year Est. Return
36.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.32%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
-$123M
(-4.3%)
Cap. Flow
-$215M
Cap. Flow
% of AUM
-7.9%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,200
New
704
Increased
294
Reduced
353
Closed
800
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$85.8M |
| 2 |
Steel Dynamics
STLD
|
+$50.2M |
| 3 |
McKesson
MCK
|
+$43.7M |
| 4 |
STOR
STORE Capital Corporation
STOR
|
+$38.2M |
| 5 |
Arch Capital
ACGL
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$149M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$147M |
| 3 |
NLSN
Nielsen Holdings plc
NLSN
|
+$44.3M |
| 4 |
CoStar Group
CSGP
|
+$44.2M |
| 5 |
Chevron
CVX
|
+$43.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.28% |
| 2 | Healthcare | 12.35% |
| 3 | Industrials | 12.24% |
| 4 | Technology | 10.34% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNPR
601
DELISTED
Juniper Networks
JNPR
| $662K | 0.02% |
+20,713
| New | +$627K |
|
602
Ligand Pharmaceuticals
LGND
$6.02B
| $660K | 0.02% |
9,876
+266
| +3% | +$17.3K |
|
|
PDCO
603
DELISTED
Patterson Companies, Inc.
PDCO
| $659K | 0.02% |
+23,517
| New | +$649K |
|
|
MVLA
604
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $657K | 0.02% |
65,218
-19,700
| -23% | -$197K |
|
605
Heritage Financial
HFWA
$1.24B
| $656K | 0.02% |
+21,394
| New | +$669K |
|
606
Newmark Group
NMRK
$2.73B
| $655K | 0.02% |
+82,133
| New | +$685K |
|
|
CBAY
607
DELISTED
Cymabay Therapeutics
CBAY
| $652K | 0.02% |
103,997
-180,163
| -63% | -$685K |
|
608
Strategic Education
STRA
$1.71B
| $652K | 0.02% |
8,322
+862
| +12% | +$63.9K |
|
609
Gentex
GNTX
$4.88B
| $649K | 0.02% |
+23,785
| New | +$635K |
|
610
Atkore
ATKR
$2.59B
| $646K | 0.02% |
5,695
-14,437
| -72% | -$1.51M |
|
|
BRKL
611
DELISTED
Brookline Bancorp
BRKL
| $646K | 0.02% |
+45,630
| New | +$610K |
|
612
Dave & Buster's
PLAY
$343M
| $644K | 0.02% |
18,158
-1,462
| -7% | -$52.9K |
|
613
Hilltop Holdings
HTH
$2.29B
| $642K | 0.02% |
21,402
-40,714
| -66% | -$1.16M |
|
614
Revvity
RVTY
$12.3B
| $632K | 0.02% |
4,505
+12
| +0.3% | +$1.61K |
|
615
AutoZone
AZO
$48.3B
| $631K | 0.02% |
256
-980
| -79% | -$2.37M |
|
|
MBAC
616
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
| $629K | 0.02% |
62,760
| – | – |
|
|
GTHX
617
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $629K | 0.02% |
+115,751
| New | +$970K |
|
618
Perdoceo Education
PRDO
$1.9B
| $628K | 0.02% |
45,170
+29,345
| +185% | +$374K |
|
619
Grocery Outlet
GO
$891M
| $628K | 0.02% |
+21,507
| New | +$675K |
|
620
St. Joe Company
JOE
$3.57B
| $627K | 0.02% |
+16,215
| New | +$581K |
|
621
Trinity Industries
TRN
$2.97B
| $625K | 0.02% |
+21,136
| New | +$589K |
|
622
Trip.com Group
TCOM
$27.5B
| $620K | 0.02% |
+18,014
| New | +$517K |
|
623
Pediatrix Medical
MD
$2.16B
| $620K | 0.02% |
41,690
-1,234
| -3% | -$20.1K |
|
|
INVX
624
Innovex International
INVX
$1.87B
| $617K | 0.02% |
22,718
+5,818
| +34% | +$139K |
|
625
Certara
CERT
$1.17B
| $615K | 0.02% |
+38,255
| New | +$555K |
|
Similar funds
ROC
IVMX
AM
JCG
JAMONY
FA
VCM
MCMI
Ergoteles's Q4 2022 Portfolio in Review
As of Q4 2022, Ergoteles held 2,200 positions worth $2.72B, down 4.3% from $2.85B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ergoteles withdrew a net $215M in Q4 2022, closing 800 positions and reducing 353 holdings. Its most notable exit was Citrix Systems Inc, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ergoteles opened a new position in McKesson worth $43.9M.
- Ergoteles's largest Q4 2022 buy was McKesson: 117,079 shares worth $43.9M.
- Ergoteles added most to iShares Biotechnology ETF in Q4 2022, an estimated $85.8M increase.
- Ergoteles's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $41.8M.
- Ergoteles fully exited Citrix Systems Inc in Q4 2022, selling an estimated $149M.
- Ergoteles's ten largest holdings make up 17% of its $2.72B portfolio in Q4 2022.
- Ergoteles opened 704 new positions and closed 800 in Q4 2022.
- Ergoteles's portfolio value fell 4.3% quarter-over-quarter to $2.72B.
Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.